# Eli Lilly Group Pension Plan

Eli Lilly Group Pension Plan is a Pension Fund based in Hampshire, United Kingdom.

## Overview

- **Organization type:** Pension Fund
- **Headquarters:** Hampshire, United Kingdom
- **Region:** Europe
- **Address:** Hampshire, United Kingdom
- **Assets under management:** Undisclosed

## Regulatory record

- **Reports private funds:** No

## About

Eli Lilly Group Pension Plan operates as the UK defined-benefit vehicle for Eli Lilly and Company, the Indianapolis-headquartered pharmaceutical firm. The plan is governed by Eli Lilly Group Pension Trustees Ltd, a dedicated corporate trustee entity that separates scheme oversight from the parent company's commercial operations. Susan Ridlen served as Chief Investment Officer until 2025, leading the plan's investment strategy across multiple market cycles. The plan deploys capital across traditional institutional asset classes, with an allocation shaped by pension-liability matching requirements. Core exposures include investment-grade fixed income, inflation-linked gilts, and global equities, with additional allocations to private credit and real assets for yield enhancement. The plan has historically participated in annuity buy-in transactions — a liability-hedging tool common among maturing UK defined-benefit schemes — including a recorded annuitization under the "Lilly Lifestyle" vehicle. Geographic exposure concentrates in the UK and developed Europe, with selective diversification into North American and Asian markets through commingled fund structures. As a corporate pension scheme, the plan's scale is determined by the size of Eli Lilly's UK workforce and the associated benefit obligations. The trustee board, operating at arm's length from Eli Lilly's treasury function, oversees actuarial valuations and funding-level negotiations with the sponsor. In 2025, the plan underwent a leadership transition as Susan Ridlen retired from the CIO role, marking a succession milestone for the scheme's investment governance. The appointment of her successor — not yet publicly disclosed — will set the plan's strategic direction through the next funding cycle. The plan's structural differentiator is its position as a corporate-defined-benefit scheme inside a fully funded multinational sponsor — a configuration that gives it access to institutional-level investment management while remaining legally segregated from Eli Lilly's balance sheet. Unlike pooled local-government pension schemes or independent master trusts, the plan operates as a single-sponsor entity, giving trustees direct influence over contribution rates and benefit design. This governance model allows the plan to pursue a patient, low-turnover investment strategy without the peer-pressure dynamics that shape multi-employer or local-authority pools.

## People

- Susan Ridlen — Former Chief Investment Officer

## Questions

### Who oversees investment decisions at the Eli Lilly Group Pension Plan?

Investment oversight rests with the trustee board of Eli Lilly Group Pension Trustees Ltd, the dedicated corporate trustee entity for the UK scheme. Day-to-day portfolio management was historically led by the Chief Investment Officer — a role held by Susan Ridlen until her 2025 retirement. The trustees operate independently from Eli Lilly's corporate treasury, with a fiduciary duty to plan beneficiaries.

### What is the "Lilly Lifestyle" annuity vehicle?

Lilly Lifestyle - Annuity is a recorded annuity buy-in structure associated with the UK pension plan. These arrangements transfer a portion of the plan's defined-benefit liabilities to an insurance company in exchange for a bulk-premium payment, reducing longevity and investment risk on the sponsoring employer's balance sheet. Such transactions are common among UK corporate schemes seeking to de-risk as they mature.

### Where does the plan's investment management sit geographically?

The plan is administered from the United Kingdom, where Eli Lilly's British subsidiary maintains operations. Investment mandates are executed through external fund managers and pooled institutional vehicles, with trustees retaining asset-allocation and manager-selection authority. The scheme does not operate as a direct-investing institution.

## Related profiles

- [Eli Lilly & Company OPEB](https://altss.com/profile/eli-lilly-company-opeb)
- [Elyseum Investment](https://altss.com/profile/elyseum-investment)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/eli-lilly-group-pension-plan

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology